Your Pain Medication Silences the Joint.
The Cartilage Keeps Dying Underneath.
NSAIDs mask the pain signal while cartilage continues to degrade. Amla's emblicanins address the upstream cause — oxidative stress destroying chondrocytes — and activate AMPK to generate new mitochondria inside the joint cells that rebuild cartilage.
Try Loomi Amla →
Your Ibuprofen Stops the Pain.
It Also Accelerates the Damage.
NSAIDs silence the inflammation signal. But published research shows they also inhibit cartilage repair, damage the GI lining, and stress the kidneys — all while the joint deteriorates underneath the quiet.
NSAIDs Inhibit Cartilage Repair
Ibuprofen and naproxen suppress prostaglandins — including the ones your chondrocytes need to rebuild cartilage matrix. The pain stops. The repair also stops. Published research shows long-term NSAID use is associated with accelerated cartilage degradation in osteoarthritis.
GI Bleeding & Kidney Damage
16,500 Americans die annually from NSAID-related GI complications. Long-term use damages stomach lining, increases ulcer risk, and strains kidneys. Your doctor says "take it with food" — but chronic use carries risk regardless of when you take it.
Cortisone Injections Weaken Cartilage
Steroid injections reduce inflammation for 6-12 weeks. But published research shows repeated injections accelerate cartilage loss and joint destruction. Maximum 3-4 per year. Each one buys time while the joint gets worse underneath.
The Knee Replacement Endpoint
$30,000-$50,000. 6-12 month recovery. Artificial joints last 15-20 years — then need revision surgery. This is where unaddressed cartilage degradation leads. Every year of managing pain without protecting cartilage brings this endpoint closer.
You've Tried Everything.
Here's Why None of It Could Have Worked.
Every joint supplement provides building blocks. None addresses why your cartilage cells can't USE those building blocks.
Glucosamine & chondroitin — provide raw cartilage building blocks. But the chondrocytes (cartilage cells) that USE those materials are dying from oxidative stress. Their mitochondria are failing. Delivering bricks to a construction site with no workers.
Turmeric / curcumin — reduces inflammation. Helpful for symptoms. But anti-inflammation alone doesn't regenerate cartilage or restore the cellular energy chondrocytes need to rebuild.
Collagen — provides structural protein the joint uses. But your cartilage cells need ENERGY to incorporate that collagen into new tissue. Without mitochondrial power, the collagen passes through unused.
MSM, fish oil, Boswellia — anti-inflammatory and structural support. Same problem: the cells that would use these compounds are running on empty. The nutrients are there. The cellular energy isn't.
The Missing Piece: Cellular Energy
Chondrocytes — the cells that maintain and rebuild cartilage — are entirely dependent on mitochondrial energy. When oxidative stress kills their mitochondria, they can't repair. Can't rebuild. Can't maintain. It doesn't matter how much glucosamine or collagen you give them. A cell without energy is a cell that can't work. Every supplement you've tried provided materials. None restarted the engine.
Protect the Cartilage. Power the Cells.
Let the Joint Rebuild.
Amla addresses the upstream cause — oxidative stress destroying chondrocytes — and restores the mitochondrial energy they need to actually repair cartilage tissue.
Cascading Antioxidants Stop Cartilage Oxidation
Oxidative stress is the primary driver of cartilage degradation in osteoarthritis. Free radicals attack chondrocytes, damage the cartilage matrix, and trigger the inflammatory cascade that causes pain and stiffness. Amla's emblicanins — unique cascading antioxidants that transform from one active form to another during radical scavenging — neutralize this oxidative assault at the cellular level. Published research confirms "potent anti-inflammatory activity" in both acute and chronic inflammation models, with a safety profile superior to NSAIDs and NO gastric damage.
Published Chondroprotective Activity
In a study using cartilage from actual osteoarthritis patients, amla extract demonstrated significant chondroprotective activity — protecting cartilage matrix from degradation. The researchers noted that amla's long-term chondroprotective effect was "comparable to glucosamine sulphate in magnitude and potency." This is the first and only fruit extract with published chondroprotective data on HUMAN osteoarthritis cartilage.
AMPK Activation Rebuilds Mitochondria in Joint Cells
Here's what separates amla from every joint supplement on the market: AMPK activation. Amla triggers AMP-activated protein kinase — the master switch for mitochondrial biogenesis. New mitochondria inside chondrocytes. New cellular energy. For the first time, your cartilage cells have the POWER to actually use the glucosamine, the collagen, the building blocks that have been sitting there doing nothing because the engine was dead. This is why amla works where everything else you've tried hasn't — it restarts the engine.

One Compound. Three Actions.
Protect. Power. Rebuild.
Amla doesn't mask pain. It addresses the oxidative damage destroying your cartilage cells, restores their mitochondrial energy, and provides published chondroprotective support — all without GI risk.
Standardized Amla Extract (60% Emblicanins)
The most concentrated source of cascading antioxidants ever measured in a food. Emblicanin-A neutralizes free radicals and transforms into Emblicanin-B during the process — which is ALSO an antioxidant. This sustained protection stops the oxidative stress that's destroying your chondrocytes (cartilage cells) and triggering the inflammatory cascade responsible for joint pain and stiffness. Published anti-inflammatory research shows potency comparable to conventional NSAIDs — without gastric damage.
AMPK Activation → Chondrocyte Energy Restoration
Amla activates AMPK, triggering mitochondrial biogenesis — the production of new mitochondria inside your cartilage cells. This is the mechanism no other joint supplement provides: your chondrocytes finally have the ENERGY to use the building materials (glucosamine, collagen, MSM) that have been sitting there unused because the cellular power plants were dead. Restoration, not just raw materials.
Published Chondroprotective Data
In a study using cartilage from actual osteoarthritis patients, amla extract demonstrated significant chondroprotective activity — protecting cartilage matrix from degradation. Long-term chondroprotective effect was comparable to glucosamine sulphate in magnitude and potency. This is the only fruit extract with published chondroprotective data on human OA cartilage. Not theory. Not animal models. Human arthritic cartilage.
The First 12 Weeks
Joint repair is slow because cartilage has no blood supply — nutrients reach it only through joint fluid. Consistent daily support over 12 weeks is when the real shift happens.
Inflammation Begins Declining
Amla's anti-inflammatory effect is measurable within the first two weeks. Systemic inflammation markers (hsCRP) begin dropping. You may notice slightly less morning stiffness — the kind that loosens up after moving for 10-15 minutes. The oxidative assault on your cartilage cells is slowing down.
Stiffness Begins Easing
As oxidative stress decreases and AMPK activation begins generating new mitochondria in chondrocytes, the morning stiffness window typically shortens. Many customers report going from 20-30 minutes of morning stiffness to 5-10. The joint isn't healed — but the inflammatory fire is cooling and the repair cells are waking up.
Functional Improvement
This is when most people notice they're doing things they'd stopped doing. Walking further. Taking stairs with less hesitation. Reaching overhead without wincing. The improvements aren't dramatic — they're gradual. You notice them retrospectively: "Wait, I just walked the dog without thinking about my knee."
Sustained Relief + Reduced NSAID Dependency
By week 12, the full anti-inflammatory and chondroprotective effects are in place. Many customers report significantly reduced NSAID use — from daily ibuprofen to occasional. Some stop NSAIDs entirely (with doctor's guidance). The joint is being protected and supported at the cellular level, not just silenced chemically.
Real People. Real Joint Recoveries.
"Both knees — stage 2 OA. I was taking 800mg ibuprofen twice a day and my gastroenterologist was worried about my stomach lining. I've tried glucosamine for two years. Turmeric for one year. Collagen for six months. None made a meaningful difference. Started amla 4 months ago. By week 6 I reduced my ibuprofen to once a day. By week 10 I take it maybe twice a week. My GI doctor is relieved. My knees aren't perfect but they're functional without daily NSAIDs for the first time in three years."
"My orthopedist said I was 'a couple years from a knee replacement.' I'm 61. I wasn't ready. I started amla because the mitochondrial mechanism made sense to me — my cells need energy to repair, and nothing I was taking addressed that. Three months in: my morning stiffness went from 25 minutes to about 5. I walked 18 holes of golf last weekend. My orthopedist said 'whatever you're doing, keep doing it.'"
"I'm a carpenter. 58. My hands were getting so stiff in the mornings I couldn't grip my tools until 10am. Cortisone shots gave me 2 months of relief each time, then the stiffness came back worse. My wife read about amla and the chondroprotective research. Five months in — I'm gripping tools at 7am. The stiffness isn't gone completely but it's manageable. More importantly, it's not getting WORSE for the first time in years. The direction changed."
"Honest review at 7 weeks: I notice a modest improvement in morning stiffness and I've cut my naproxen from twice daily to once. But I still have pain going down stairs and my right knee still swells after long walks. I'm not blown away yet but I understand this takes time — cartilage repairs slowly. The fact that ANYTHING changed after glucosamine and turmeric did nothing for two years is enough to keep me going through week 12. Four stars for now."
Everything You Need to Know
Don't stop NSAIDs cold turkey. The goal is to reduce your reliance on them over time as amla's anti-inflammatory and chondroprotective effects build. Many customers report gradually reducing NSAID use over 6-10 weeks. Let your body tell you when you need less — and always discuss medication changes with your doctor.
Glucosamine and chondroitin provide raw building materials for cartilage — like delivering bricks to a construction site. Amla provides the ENERGY for the construction workers (chondrocytes) to actually use those bricks. Through AMPK activation, amla generates new mitochondria inside cartilage cells — restoring the cellular power they need to incorporate building materials into new tissue. Interestingly, the published chondroprotective study found amla's cartilage-protective effect comparable to glucosamine in magnitude. They work through completely different mechanisms and can be taken together.
Yes. Amla works through a fundamentally different mechanism than glucosamine, chondroitin, MSM, collagen, or turmeric. It addresses the ENERGY layer — mitochondrial function inside cartilage cells. Your existing supplements provide materials and anti-inflammatory support. Amla restores the cellular power to USE those materials. They're complementary, not redundant.
Published research shows amla induces apoptosis (programmed cell death) of osteoclasts — the cells that destroy bone and cartilage in rheumatoid arthritis. The anti-inflammatory effect (hsCRP reduction of 53.8% in clinical trial) is relevant to both OA and RA. However, RA is an autoimmune condition that typically requires disease-modifying drugs (DMARDs). Amla may complement RA treatment but should NOT replace prescribed RA medications. Always consult your rheumatologist.
Amla (Phyllanthus emblica, Indian gooseberry) has been the cornerstone of Ayurvedic medicine for 5,000 years — called "the nurse" for its restorative properties. It's the most widely used medicinal plant in India. But it's virtually unknown in Western supplement markets because the standardized clinical-grade extract (60% emblicanins) only became available through modern pharmaceutical processing in the last 15 years. The published clinical data is newer than the plant's traditional use.
No. In fact, published research specifically confirmed that amla has antiulcerogenic (stomach-protective) activity — the opposite of NSAIDs. The researchers noted this as a "complementary advantage" to its anti-inflammatory effect: it reduces inflammation WITHOUT damaging the stomach lining. No GI bleeding risk. No kidney stress. This is one of the primary reasons people switch from daily NSAIDs to amla-based support.
Most customers notice reduced morning stiffness around weeks 3-5. Functional improvement (walking further, taking stairs more easily) typically appears around weeks 6-9. Reduced NSAID dependency is most common by weeks 8-12. Cartilage has no blood supply — it receives nutrients only through joint fluid — so repair is inherently slow. We recommend a full 90-day commitment, which is why the guarantee matches.
90 days. No questions asked. Joint repair takes time. If you don't notice meaningful improvement in stiffness, mobility, or NSAID dependency within 90 days, email us for a full refund. No hoops. No fine print.
Stop Silencing the Joint.
Start Repairing It.
NSAIDs mask the pain while cartilage deteriorates. Amla protects the cartilage, powers the cells that rebuild it, and reduces inflammation — without a single GI side effect.
Try Loomi Amla →Important: Loomi Amla is a dietary supplement intended to support healthy joint function and cartilage maintenance. This product is not a replacement for prescribed arthritis medications, physical therapy, or surgical interventions. Do not stop NSAIDs, DMARDs, or any prescribed medication without consulting your doctor. If symptoms improve, discuss medication adjustments with your healthcare provider.
*Chondroprotective data is from published in vitro studies using cartilage from osteoarthritis patients. Anti-inflammatory data is from published rodent models of acute and chronic inflammation. Cardiovascular clinical trial data (hsCRP reduction) is from a randomized, double-blind, placebo-controlled human trial. Individual results vary. Testimonials represent individual experiences and are not guaranteed.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
© 2026 Loomi Nutrition. All rights reserved.